Analgesia through FKBP51 inhibition at disease onset confers lasting relief from sensory and emotional chronic pain symptoms

Hestehave S., Florea R., Singleton S., Fedorec AJH., Caxaria S., Morgan O., Kopp KT., Brown L., Heymann T., Sikandar S., Hausch F., Peirson S., Géranton S.

DOI

10.1101/2024.11.01.621278

Type

Preprint

Publication Date

2024-01-01T00:00:00+00:00

Permalink More information Close